Search Login Register
cicaprost
Summary
35
relevant articles (5 outcomes,
5 trials/studies)
found for this Bio-Agent
Description:
RN given refers to (3aS-(2E,3aalpha,4alpha(3R*,4R*),5beta,6aalpha))-isomer
Also Known As:
13,14-didehydro-16,20-dimethyl-3-oxa-18,18,19,19-tetradehydro-6-carbaprostaglandin I2; 5-(7-hydroxy-6-(3-hydroxy-4-methylnona-1,6-diynyl)-bicyclo(3.3.0)octan-3-yliden)-3-oxapentanoic acid; ZK 96480; ZK-96480; cicaprost dihydrochloride
Key Diseases for which cicaprost is
Relevant
-
Neoplasm Metastasis (Metastasis)
:
2 outcomes 4 studies in 10 results
-
Neoplasms (Cancer)
:
2 outcomes 3 studies in 10 results
-
Systemic Scleroderma (Systemic Sclerosis)
:
1 outcome 1 study in 2 results
-
Hypercholesterolemia
:
1 outcome in 4 results
-
Adhesions
:
1 outcome in 2 results
Show All >>
Drugs Related to cicaprost
-
Epoprostenol (Prostacyclin)
-
Messenger RNA (mRNA)
-
Interleukin-1beta (Interleukin 1 beta)
-
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
-
tyramine-deoxysorbitol
-
Iloprost (Ventavis)
-
Aspirin (Acetylsalicylic Acid)
-
fluprostenol
-
Cytostatic Agents
-
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
Show All >>
Therapies Related to cicaprost
-
Lasers (Laser)
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.